The pathological evolution of IPF is strongly regulated by the entry of inflammatory cytokines and inflammatory mediators, such as IL-6, IL-1β, TNF-α, and TGF-β, into the alveolar space (Akdis et al. 2016). The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.